MXIM - Maxim Integrated Products Inc Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Maxim Integrated Products Inc (MXIM)

Other Ticker:

Sector • Technology Industry • Semiconductors

Industry • Semiconductors

Sector • Technology

Price: $68.6900 $-0.40

-0.579%

Day's High:	$69.524	Week Perf:	-0.28 %
Day's Low:	$ 68.32	30 Day Perf:	6.55 %
Volume (M):	5,037	52 Wk High:	$ 73.52
Volume (M$):	$ 345,985	52 Wk Avg:	$58.01
Open:	$68.72	52 Wk Low:	$41.93

MXIM Charts & Quotes

MXIM Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	18,655
Shares Outstanding (Millions)	272
Employees	8,250
Revenues (TTM) (Millions $)	2,203
Net Income (TTM) (Millions $)	815
Cash Flow (TTM) (Millions $)	-16
Capital Exp. (TTM) (Millions $)	82

Maxim Integrated Products Inc
Maxim Integrated Products, Inc., designs, develops, manufactures, and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits. The Company also provides a range of high-frequency design processes and capabilities that can be used in custom designs. The analog market is fragmented and characterized by many diverse applications, a great number of product variations, and, as to many circuit types, relatively long product life cycles. Maxim’s objective is to develop and market both proprietary and industry-standard analog integrated circuits that meet the increasingly stringent quality standards demanded by customers. Based on product announcements by its competitors, Maxim believes that in the past 21 years it has developed more products for the analog market, including proprietary and second-source products, than any of its competitors over the same period.

Company Address: 160 Rio Robles San Jose 95134 CA
Company Phone Number: 601-1000 Stock Exchange / Ticker: NASDAQ MXIM

MXIM is expected to report next financial results on October 22, 2020.

Next quarterly dividend payout on September 07, 2020.

Maxim Integrated Products Inc 's Segments


United States	Segment	11.03 %	of total Revenue
Europe	Segment	16.34 %	of total Revenue
China	Segment	39.86 %	of total Revenue
Rest of Asia	Segment	30.21 %	of total Revenue
Rest World	Segment	2.56 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Maxim Integrated Products Inc provided quarterly revenue outlook. • Earnings Outlook Maxim Integrated Products Inc provided quarterly earnings guidance.

Geographic Revenue Dispersion
United States	11.86 %
Europe	14.64 %
China	39.93 %
Japan	2.76 %
Rest Asia	28.05 %
Rest World	2.76 %

News

Fox Factory Holding Corp

EPS Drops, Sales Lower

In the second quarter Fox Factory Holding Corp earnings per share plummeted by -45.76% of $0.32 per share compared to $0.59 a year ago and eps soared by 52.38 % from $0.21 per share from the previous quarter.

Sales contracted by -4.69% to $183.10 millions from $192.12 millions in the same quarter a year ago and sequentially Sales decreased by -0.68% from $184.36 millions.

Assembly Biosciences inc

EPS Fell while Sales More than Doubled

Despite very strong Sales growth of 1178.44% year on year to $39.38 millions in the second quarter, company faced turn a round at $0.19.

Fate Therapeutics Inc

Fate Therapeutics Inc announced second quarter operating deficit of $-28.707 millions

Strong Sales growth in the second quarter, by 94% to $5.47 millions helped to cut the loss to $-0.35 per share, from $-0.36 in same quarter a year ago.

Constellation Pharmaceuticals Inc

Logged a Loss but Revenues Unchanged

In the second quarter Constellation Pharmaceuticals Inc lost money of $-0.70 per share compared to $-0.80 a year ago and increased losses from $-0.61 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Discovery Inc

Sharp drop in EPS, Sales Weak

In the second quarter Discovery Inc eps dived by -69.92% of $0.40 per share compared to $1.33 a year ago and income faded by -27.27% from $0.55 per share from the previous quarter.

Sales declined in double digits by -11.92% to $2.54 billions from $2.89 billions in the same quarter a year ago and sequentially Sales decreased by -5.29% from $2.68 billions.

MXIM's Valuation	Current
Price to Earnings PE Ratio (TTM)	23.19
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	8.47
Price to Sales (Expected)	-
Price to Book	11.52
PEG (TTM)	0.83

MXIM's Financial Strength	Current
Quick Ratio	0.17
Working Capital Ratio	2.43
Leverage Ratio (MRQ)	1.12
Total Debt to Equity	0.61
Interest Coverage (TTM)	374.32
Debt Coverage (TTM)	0.79

Per Share	Current
Earnings (TTM)	2.96 $
Revenues (TTM)	8.11 $
Cash Flow (TTM)	-0.06 $
Cash	0.17 $
Book Value	5.96 $
Dividend (TTM)	1.9 $

MXIM's Efficiency	Current
Revenue per Employee (TTM)	266,978
Net Income per Employee (TTM)	98,782
Receivable Turnover Ratio (TTM)	6.05
Inventory Turnover Ratio (TTM)	3.35
Asset Turnover Ratio (TTM)	1.13

MXIM's Profitability Ratio	Current
Gross Margin	65.21 %
Operating Margin	32.63 %
Net Margin	28.69 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	41.85 %
Return On Investment (TTM)	24.81 %
Return On Equity (TTM)	46.75 %
Dividend Yield	2.77 %
Payout Ratio (TTM)	64.16 %

MXIM's Valuation
Price to Earnings PE Ratio (TTM)	23.19
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	8.47
Price to Sales (Expected)	-
Price to Book	11.52
PEG (TTM)	0.83

MXIM's Financial Strength
Quick Ratio	0.17
Working Capital Ratio	2.43
Leverage Ratio (MRQ)	1.12
Total Debt to Equity	0.61
Interest Coverage (TTM)	374.32
Debt Coverage (TTM)	0.79

Per Share
Earnings (TTM)	2.96 $
Revenues (TTM)	8.11 $
Cash Flow (TTM)	-0.06 $
Cash	0.17 $
Book Value	5.96 $
Dividend (TTM)	1.9 $

• View Valuation Comparisons

• View Growth Rates Comparisons

MXIM's Efficiency
Revenue per Employee (TTM)	266,978
Net Income per Employee (TTM)	98,782
Receivable Turnover Ratio (TTM)	6.05
Inventory Turnover Ratio (TTM)	3.35
Asset Turnover Ratio (TTM)	1.13

MXIM's Profitability Ratio
Gross Margin	65.21 %
Operating Margin	32.63 %
Net Margin	28.69 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	41.85 %
Return On Investment (TTM)	24.81 %
Return On Equity (TTM)	46.75 %
Dividend Yield	2.77 %
Payout Ratio (TTM)	64.16 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income fell by	MXIM's customers Net margin fell to 28.69 %
-17.35 %	10.63 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

ADI		1.28%
TXN		4.71%
SWKS	-0.83%
QRVO		2.2%
ON		1.17%
AVGO		2.9%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CVNA's Profile Stock Price CVNA's Financials Business Description Fundamentals Charts & Quotes CVNA's News Suppliers CVNA's Competitors Customers & Markets Economic Indicators CVNA's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

MXIM Company Profile

EPS Drops, Sales Lower

EPS Fell while Sales More than Doubled

Fate Therapeutics Inc announced second quarter operating deficit of $-28.707 millions

Logged a Loss but Revenues Unchanged

Sharp drop in EPS, Sales Weak